[Urinary excretion of riboflavin following its intravenous administration in Basedow's disease; criterior of riboflavin deficiency].
D061605:Administration, Intravenous; D006111:Graves Disease; D006980:Hyperthyroidism / Q000628:therapy*; D012256:Riboflavin / Q000627:therapeutic use*; D012257:Riboflavin Deficiency
D012256:Riboflavin
HYPERTHYROIDISM/therapy; VITAMIN B2/therapeutic use
O vydelenii riboflavina s mochoi posle vnutrivennogo ego vvedeniia bol'nym bazedovoi bolezn'iu; k voprosu o kriteriia riboflavinovoi nedostatochnosti.